+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia



Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia



Nephrology, Dialysis, Transplantation 20(12): 2865-2865



There is limited information whether the use of ciprofloxacin in the neonatal period affects the linear growth of very low birth weight (VLBW) babies in infancy. This was a retrospective cohort study on VLBW babies followed up until 12 months corrected age (12-mCA).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012689354

Download citation: RISBibTeXText

PMID: 16115841

DOI: 10.1093/ndt/gfi110


Related references

Therapeutic failure of cinacalcet in a renal transplant patient. Nephrology Dialysis Transplantation 21(3): 824; Author Reply 824, 2006

Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. American Journal of Transplantation 6(10): 2391-2395, 2006

Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet. Clinical Nephrology 65(5): 374-377, 2006

Hypercalcaemia due to hyperparathyroidism in a patient with chronic renal failure and renal carcinoma. Journal of Clinical Pathology 32(3): 234-239, 1979

Successful use of cinacalcet HCl in a patient with end-stage renal failure and refractory secondary hyperparathyroidism due to parathyromatosis. Clinical Nephrology 67(3): 188-192, 2007

Cinacalcet impact on calcium homeostasis and bone remodeling in 13 renal transplanted patients with hyperparathyroidism and hypercalcaemia. Nephrologie and Therapeutique 8(1): 47-53, 2012

Use of cinacalcet in a patient on long-term dialysis with end-stage renal failure and refractory secondary hyperparathyroidism. Nephrology, Dialysis, Transplantation 22(2): 637-640, 2006

Effects of cinacalcet in renal transplant patients with hyperparathyroidism. American Journal of Nephrology 35(4): 341-348, 2012

Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrology Dialysis Transplantation 22(8): 2362-2365, 2007

Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 82(5): 675-680, 2006

Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrology Dialysis Transplantation 20(7): 1315-1319, 2005

Renal failure, hyperparathyroidism and hypercalcaemia in a dog. Australian Veterinary Journal 55(4): 177-180, 1979

Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet. Transplantation Proceedings 38(10): 3514-3516, 2006

Cinacalcet improves bone mineral density in a renal transplant recipient with persistent hyperparathyroidism. Clinical Nephrology 69(3): 231-232, 2008

Hypercalcemia Due To Resistant Hyperparathyroidism In Renal Transplant Patients Treated With The Calcimimetic Agent Cinacalcet. Transplantation 82(Suppl 2): 954-955, 2006